If a patient's osteoarthritis causes chronic inflammation and increased prostaglandin E2 (PGE2) production in chondrocytes, which consequence is most likely regarding the nuclear factor kappa B (NF-κB) pathway?

💡 Explanation

Inflammation, driven by increased PGE2, activates the NF-κB pathway in chondrocytes, because PGE2 binds to its receptors and triggers a signaling cascade that promotes NF-κB translocation to the nucleus. Therefore, this leads to enhanced expression of inflammatory mediators rather than the other options that would reduce inflammation.

• A patient with severe edema receives a loading dose of a water-soluble drug. If the drug's volume of distribution is typically 15L, what effect dominates?
• A woman experiences recurrent luteal phase defects despite normal ovulation timing and estrogen levels. Which hormonal consequence is most likely limiting implantation?
• Why does increased TSH receptor endocytosis occur during prolonged exposure to high levels of thyroid-stimulating immunoglobulins (TSI) in Graves' disease, ultimately reducing thyroid hormone synthesis?
• Why does blocking urea transport from the collecting duct into the medullary interstitium impair the kidney's ability to concentrate urine?
• Why does chronic intense musculoskeletal pain from nerve damage persist despite taking NSAIDs?
• Why does a subsequent exposure to pollen provoke a stronger allergic reaction in sensitized individuals compared to the initial exposure?